Moving From Bench To Bedside

Reimbursement Case Brief


A prominent translational medicine program had rejected funding to help develop a real-time ICU heart monitor.  The program’s board had determined that there wasn’t a viable economic case for bringing the device to market — assuming that critical care departments would see it as an unnecessary added expense.


JR Associates was asked to take a closer look at the technology’s commercial potential.  After a thorough discovery and assessment process, we determined that the monitor had greater potential as a diagnostic tool beyond the ICU. In this application, it has potential to help doctors treat cardiac patients faster, more accurately, and in a less invasive manner than other modalities.


By establishing a use case that maps more closely with healthcare provider realities, we repositioned the tool in a way that justified further development funding, and opened the door to a sustainable commercial business model.

We’re ready to help your organization drive medical innovation forward

Learn more about our Accelerator Advisory Services
See all Case Briefs

Need reimbursement guidance to help propel your life science research?
Contact Us.